pI: 5.5525 |
Length (AA): 289 |
MW (Da): 32960 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 288 | 2i7t (A) | 10 | 235 | 48.00 | 0.00000037 | 1 | 1.13578 | 0.55 |
16 | 139 | 1e5d (A) | 34 | 155 | 16.00 | 0.27 | 0.32 | 0.630566 | -0.38 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127285)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G61010 | cleavage and polyadenylation specificity factor subunit 73-I |
Babesia bovis | BBOV_IV001630 | cleavage and polyadenylation specifity factor |
Brugia malayi | Bm1_34605 | cpsf3-prov protein |
Candida albicans | CaO19.5486 | subunit of polyadenylation factor I |
Candida albicans | CaO19.12941 | subunit of polyadenylation factor I |
Caenorhabditis elegans | CELE_Y67H2A.1 | Protein CPSF-3 |
Cryptosporidium hominis | Chro.80059 | cleavage and polyadenylation specifity factor protein |
Cryptosporidium parvum | cgd8_460 | cleavage and polyadenylation specifity factor protein, CPSF metallobeta-lactamase |
Dictyostelium discoideum | DDB_G0274799 | DNA repair metallo-beta-lactamase domain-containing protein |
Drosophila melanogaster | Dmel_CG7698 | Cleavage and polyadenylation specificity factor 73 |
Echinococcus granulosus | EgrG_001021200 | Cleavage and polyadenylation specificity factor |
Entamoeba histolytica | EHI_136170 | cleavage and polyadenylation specificity factor 73 kDa subunit, putative |
Echinococcus multilocularis | EmuJ_001021200 | Cleavage and polyadenylation specificity factor |
Giardia lamblia | GL50803_4498 | Cleavage and polyadenylation specificity factor, 73 kDa subunit |
Homo sapiens | ENSG00000119203 | cleavage and polyadenylation specific factor 3, 73kDa |
Leishmania braziliensis | LbrM.20.3010 | cleavage and polyadenylation specificity factor, putative |
Leishmania donovani | LdBPK_343210.1 | cleavage and polyadenylation specificity factor, putative |
Leishmania infantum | LinJ.34.3210 | cleavage and polyadenylation specificity factor, putative |
Leishmania major | LmjF.34.3430 | cleavage and polyadenylation specificity factor, putative |
Leishmania mexicana | LmxM.33.3430 | cleavage and polyadenylation specificity factor, putative |
Loa Loa (eye worm) | LOAG_06840 | cpsf3-prov protein |
Mus musculus | ENSMUSG00000054309 | cleavage and polyadenylation specificity factor 3 |
Neospora caninum | NCLIV_014990 | hypothetical protein |
Oryza sativa | 4334816 | Os03g0852900 |
Plasmodium berghei | PBANKA_1302400 | cleavage and polyadenylation specificity factor subunit 3, putative |
Plasmodium falciparum | PF3D7_1438500 | cleavage and polyadenylation specificity factor subunit 3, putative |
Plasmodium knowlesi | PKNH_1243900 | cleavage and polyadenylation specificity factor subunit 3, putative |
Plasmodium vivax | PVX_221290 | unspecified product |
Plasmodium vivax | PVX_118570 | cleavage and polyadenylation specificity factor, putative |
Plasmodium vivax | PVX_209290 | unspecified product |
Plasmodium yoelii | PY00665 | cleavage and polyadenylation specificity factor, 73 kDa subunit |
Saccharomyces cerevisiae | YLR277C | Ysh1p |
Schistosoma japonicum | Sjp_0310280 | Cleavage and polyadenylation specificity factor subunit 3, putative |
Schistosoma japonicum | Sjp_0011280 | Cleavage and polyadenylation specificity factor subunit 3, putative |
Schistosoma mansoni | Smp_084380 | cleavage and polyadenylation specificity factor-related |
Schmidtea mediterranea | mk4.015559.00 | |
Schmidtea mediterranea | mk4.000158.08 | |
Schmidtea mediterranea | mk4.030240.00 | |
Schmidtea mediterranea | mk4.005289.01 | |
Schmidtea mediterranea | mk4.000158.07 | Cleavage and polyadenylation specificity factor subunit 3 |
Trypanosoma brucei gambiense | Tbg972.4.1170 | cleavage and polyadenylation specificity factor subunit, putative |
Trypanosoma brucei | Tb927.4.1340 | cleavage and polyadenylation specificity factor subunit, putative |
Trypanosoma congolense | TcIL3000_4_840 | cleavage and polyadenylation specificity factor subunit, putative |
Trypanosoma cruzi | TcCLB.508693.10 | cleavage and polyadenylation specificity factor, putative |
Toxoplasma gondii | TGME49_285200 | cleavage and polyadenylation specifity factor protein |
Theileria parva | TP03_0560 | cleavage and polyadenylation specificity factor protein, putative |
Theileria parva | TP03_0561 | hypothetical protein |
Trichomonas vaginalis | TVAG_437970 | cleavage and polyadenylation specificity factor, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.1340 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.1340 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.1340 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.1340 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y67H2A.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y67H2A.1 | Caenorhabditis elegans | larval arrest | wormbase |
YLR277C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1302400 | Plasmodium berghei | Essential | plasmo |
TGME49_285200 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.